CLX monthly performance report
Monthly CLX research: returns, drawdown, relative strength, seasonality, and key stats.
CLX monthly report
—
Key takeaways
- Clorox (CLX) closed September 2026 at $87.76, down 10.16% for the month and −29.46% over the trailing 12 months.
- Year-to-date, CLX is −12.96%, underperforming the S&P 500 which has returned +12.08% YTD.
- The stock is trading −14.81% versus its 200-day moving average ($103.02), a cautious technical signal.
- Over the past three years, CLX has underperformed the S&P 500 by −113.54%, with a relative strength index reading of 33.4.
- Win rate over the trailing 39 months stands at 38.5% — 15 positive months versus 24 negative months.
Clorox ended September 2026 at $87.76, posting a monthly return of −10.16%. The S&P 500 returned −0.36% over the same window, leaving relative performance at −9.80%.
The current quarter stands at −8.05% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −14.81% versus the 200-day moving average ($103.02).
Year-to-date, CLX is −12.96% against SPY +12.08%, a gap of −25.04%. The stock is currently −31.92% below its 52-week high, with maximum 3-year drawdown at −49.26%.
| Period | CLX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.14% | +0.85% | −1.99% |
| 1 Week | −6.91% | −0.11% | −6.79% |
| 1 Month | −10.16% | −0.36% | −9.80% |
| 3 Months | −10.89% | +5.36% | −16.24% |
| 6 Months | −23.46% | +12.68% | −36.14% |
| YTD | −12.96% | +12.08% | −25.04% |
| 12 Months | −29.46% | +16.22% | −45.68% |
| 3 Years | −43.11% | +70.43% | −113.54% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2023 | +21.79% |
| #2 | Aug 2024 | +20.00% |
| #3 | Feb 2026 | +12.74% |
| #4 | Jan 2026 | +11.86% |
| #5 | Jun 2026 | +6.02% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −18.50% |
| #2 | Sep 2023 | −16.23% |
| #3 | May 2024 | −11.03% |
| #4 | Oct 2023 | −10.19% |
| #5 | Sep 2026 | −10.16% |
| Quarter | Return |
|---|---|
| Q2 2025 | −18.46% |
| Q3 2025 | +2.69% |
| Q4 2025 | −18.22% |
| Q1 2026 | +2.78% |
| Q2 2026 | −7.90% |
| Q3 2026 (QTD) | −8.05% |
| Year | Return |
|---|---|
| 2023 | +1.61% |
| 2024 | +13.90% |
| 2025 | −37.92% |
| 2026 | −12.96% |
| Metric | Value |
|---|---|
| 52-Week High | $128.90 (2026-02-26) |
| 52-Week Low | $84.70 (2026-05-05) |
| Current Price | $87.76 |
| 200-Day Moving Average | $103.02 |
| Price vs 200DMA | −14.81% |
| 3-Year Maximum Drawdown | −49.26% (2026-05-05) |
| Current Drawdown from 52W High | −31.92% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 33.4 |
| 3-Year Excess Return vs S&P 500 | −113.54% |
| RS Peak | 100 (Sep 2023) |
| RS Trough | 33.4 (Sep 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CLX's return for this report period?
CLX returned −10.16% in the latest monthly window ending 2026-09-11.
Has CLX outperformed SPY year to date?
YTD CLX: −12.96% vs SPY: +12.08%.
What is CLX's 12-month return?
−29.46% over the trailing 12 months.
Is CLX above or below its 200-day moving average?
Price is −14.81% versus 200DMA ($103.02).
What is the maximum drawdown in the 3-year window?
−49.26% on 2026-05-05.